Table 1.

Patient parameters used in simulated scenarios (all scenarios assumed 60-year-old patients with average comorbidities and grade 3 ER-negative tumors treated with third-generation chemotherapy with a pCR rate of 30%)

10-Year RFSHR (1/year)
Clinical T stageClinical N stageOverall (AO)pCR cohortRD cohortpCR cohortRD cohort
T1cN00.7410.820.7070.01980.0347
T2N10.5450.820.4270.01980.0851
T3N10.4560.820.3000.01980.1204
T3N20.3500.820.1490.01980.1908